OtherApr 10, 2026, 04:46 PM
Quince Therapeutics Files 2025 10-K; $64M Non-Affiliate Market Value
AI Summary
Quince Therapeutics, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2025. The company reported an aggregate market value of approximately $64.0 million for common stock held by non-affiliates as of June 30, 2025. The filing indicates the company is a non-accelerated filer and a smaller reporting company.
Key Highlights
- Filed annual report Form 10-K for fiscal year ended December 31, 2025.
- Non-affiliate market value was approximately $64.0 million as of June 30, 2025.
- Designated as a non-accelerated filer.
- Designated as a smaller reporting company.
Price Impact
More from QNCX